Ethical Limits On Altering Gene Expression Patterns.

Ethical limits on altering gene expression patterns

1. Introduction

Gene expression refers to the process through which information contained in genes is used to produce functional molecules, particularly proteins. Gene expression patterns determine when, where and to what extent particular genes become active or inactive in cells and tissues.

Modern biotechnology can alter gene expression through gene editing, RNA interference, gene silencing, epigenetic modification, gene therapy and other molecular techniques. These methods may help treat genetic disorders, cancers, metabolic diseases and other medical conditions.

However, deliberate alteration of gene expression raises significant ethical and legal concerns. Uncontrolled changes may affect normal cellular functions, produce unintended genetic effects or create long-term health consequences. Ethical regulation is therefore necessary to protect human dignity, bodily autonomy, privacy, patient safety and future generations.

2. Legal framework in India

A. Constitutional protection

Article 21 of the Indian Constitution protects life and personal liberty. It includes the rights to health, dignity, bodily integrity and privacy. Any medical intervention intended to alter gene expression must respect these constitutional protections.

Article 14 guarantees equality before the law. Genetic characteristics or differences in gene expression should not become grounds for arbitrary discrimination.

Article 19(1)(g) protects the freedom to practise a profession or carry on an occupation, subject to reasonable restrictions. Biotechnology research and genetic interventions must comply with applicable public-health and safety requirements.

B. Drugs and clinical-trial regulation

The Drugs and Cosmetics Act, 1940, and the New Drugs and Clinical Trials Rules, 2019, regulate drugs, new drugs and clinical investigations.

Gene-therapy products and certain interventions designed to modify gene expression may fall within this regulatory framework. Applicable requirements relating to product quality, safety, clinical trials and regulatory approval must be followed.

C. ICMR ethical guidelines

The ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017, provide important ethical standards for genetic research and gene therapy.

They emphasise informed consent, risk minimisation, privacy, confidentiality and protection of research participants. They also distinguish therapeutic interventions from attempts to change normal human characteristics.

D. National gene-therapy guidelines

The National Guidelines for Gene Therapy Product Development and Clinical Trials, 2019, issued by ICMR and the Department of Biotechnology, provide a regulatory and ethical framework for gene-therapy research in India.

Important principles include:

Gene expression should be specific to the intended target.

Unwanted and off-target effects should be minimised.

Risks and potential benefits must be carefully evaluated.

Human participants must provide informed consent.

Long-term monitoring should be included in clinical trials.

Germline and in-utero gene therapy are prohibited under the guidelines.

E. Environmental and biosafety regulation

The Environment (Protection) Act, 1986, and the Rules, 1989, concerning hazardous microorganisms and genetically engineered organisms or cells establish biosafety requirements for relevant genetic engineering activities.

Institutional Biosafety Committees and other designated regulatory bodies supervise applicable research and containment requirements.

3. Ethical limits

A. Informed consent

Individuals must receive adequate information before undergoing treatment intended to modify gene expression. They should understand the purpose, procedure, possible benefits, risks, alternatives and uncertainties associated with the intervention.

Consent must be voluntary and free from coercion. Special safeguards are necessary when research involves children or persons who cannot independently provide consent.

B. Prevention of unintended genetic effects

Gene expression is interconnected with numerous biological processes. Altering one gene may indirectly influence other genes, proteins or cellular functions.

Researchers must evaluate possible off-target effects, abnormal protein production, immune reactions and unexpected changes in cellular activity.

C. Protection against germline modification

Germline modification may affect reproductive cells or embryos and potentially transmit altered genetic characteristics to future generations.

The 2019 National Guidelines for Gene Therapy Product Development and Clinical Trials prohibit germline and in-utero gene therapy in India. This restriction reflects concerns about inherited consequences, scientific uncertainty and the inability of future generations to provide consent.

D. Prevention of genetic enhancement

There is an important ethical distinction between treating serious diseases and modifying normal human characteristics for enhancement.

Using genetic technologies to select or alter intelligence, physical appearance, memory or other inherited characteristics raises concerns about eugenics, inequality and discrimination.

E. Genetic privacy

Gene-expression research may reveal sensitive information about inherited conditions, disease susceptibility and individual biological characteristics.

Such information should be protected against unauthorised disclosure, commercial exploitation and discriminatory use.

F. Commercial exploitation

Companies and medical institutions may promote gene-expression modification as a guaranteed treatment without adequate scientific evidence.

Unproven therapies, misleading advertisements and excessive commercial claims can exploit patients suffering from serious illnesses. Medical interventions should be supported by appropriate evidence and regulatory oversight.

G. Justice and equal access

Advanced gene therapies may be expensive and available only to economically privileged individuals. Ethical regulation should consider fair access to treatment and prevent genetic technologies from increasing existing social inequalities.

4. Relevant case laws

There is no single Indian Supreme Court judgment specifically deciding every form of gene-expression modification. The following judgments establish constitutional and medical principles applicable to this field.

1. Justice K.S. Puttaswamy v. Union of India (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right under Article 21 and other constitutional freedoms. The judgment emphasised individual autonomy, dignity and protection of personal information.

Relevance: Genetic information and gene-expression data may reveal sensitive details about an individual's health and biological characteristics. Their collection, storage and use must respect privacy and confidentiality.

2. Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1

The Supreme Court explained the requirements of valid informed consent in medical treatment. It held that consent must be voluntary and based on adequate information about the proposed procedure.

Relevance: Patients undergoing gene-expression modification must be informed about the nature of the intervention, its risks, possible outcomes and alternatives. Consent to ordinary treatment cannot automatically authorise an experimental genetic procedure.

3. Suchita Srivastava v. Chandigarh Administration (2009) 9 SCC 1

The Supreme Court recognised reproductive autonomy and the right of a woman to make decisions concerning her reproductive choices as part of personal liberty under Article 21.

Relevance: Genetic interventions involving reproductive cells or embryos raise important questions about bodily autonomy and reproductive decision-making. The judgment provides a constitutional basis for respecting individual reproductive choices.

4. Jacob Mathew v. State of Punjab (2005) 6 SCC 1

The Supreme Court explained the principles governing medical negligence and the professional standard of care expected from medical practitioners.

Relevance: Doctors and medical institutions conducting gene-expression interventions must exercise reasonable professional skill and follow accepted medical standards. Negligent treatment resulting in injury may create legal liability.

5. Common Cause v. Union of India (2018) 5 SCC 1

The Supreme Court recognised the importance of dignity and individual autonomy in medical decision-making, particularly in relation to end-of-life care.

Relevance: The judgment supports the broader principle that medical interventions should respect individual dignity and autonomy. This principle applies to decisions involving invasive or experimental genetic treatments.

6. Vellore Citizens' Welfare Forum v. Union of India (1996) 5 SCC 647

The Supreme Court recognised the precautionary principle and the polluter-pays principle as important components of Indian environmental law.

Relevance: Genetic engineering and gene-expression research involving genetically modified organisms must consider possible environmental consequences. Appropriate preventive measures are necessary where scientific uncertainty creates risks of serious environmental harm.

5. Liability and penalties

Unethical or unlawful alteration of gene expression may attract legal consequences depending on the nature of the activity.

Medical negligence: Doctors and hospitals may face civil liability or professional disciplinary action for negligent genetic treatment.

Regulatory violations: Unapproved gene-therapy products or clinical trials may attract action under the Drugs and Cosmetics Act, 1940, and applicable rules.

Research misconduct: Failure to obtain informed consent or required ethical approval may result in suspension of research and institutional or regulatory action.

Privacy violations: Unlawful processing or disclosure of personal data may attract consequences under applicable data-protection law.

Biosafety violations: Unauthorised handling or release of regulated genetically modified organisms may attract action under applicable environmental regulations.

Consumer protection: Misleading claims concerning the safety or effectiveness of genetic treatments may attract action under consumer-protection law.

6. Regulatory safeguards

The following safeguards are important for ethical alteration of gene expression patterns:

Obtain specific and informed consent before human intervention.

Require independent ethics committee review of relevant research.

Conduct adequate preclinical and clinical safety assessments.

Evaluate unintended and off-target genetic effects.

Follow the National Guidelines for Gene Therapy Product Development and Clinical Trials, 2019.

Prohibit germline and in-utero gene therapy in accordance with applicable Indian guidelines.

Maintain long-term monitoring of clinical-trial participants.

Protect genetic information against unauthorised disclosure.

Prevent misleading claims concerning experimental gene therapies.

Ensure accountability of researchers, manufacturers and medical institutions.

7. Challenges

The principal challenge is the complexity of gene regulation. A single gene may influence several biological pathways, and changing its expression may produce unexpected effects in different tissues.

Another challenge is the distinction between therapeutic gene modification and genetic enhancement. While correcting abnormal gene activity may help treat disease, altering normal characteristics raises questions about fairness, discrimination and human dignity.

Long-term safety is also difficult to establish because some genetic interventions may produce effects that become apparent only after several years. Regulatory authorities must therefore ensure continuous monitoring and reliable scientific evaluation.

Finally, the high cost of advanced gene therapies creates concerns about unequal access and the commercial exploitation of vulnerable patients.

8. Conclusion

Altering gene expression patterns has considerable potential in modern medicine, particularly in treating genetic disorders, cancer and other serious diseases. However, these technologies may also produce unintended biological effects and raise concerns involving genetic privacy, inherited changes, human dignity and social equality.

Indian constitutional protections, the ICMR ethical guidelines and the National Guidelines for Gene Therapy Product Development and Clinical Trials, 2019, provide an important framework for responsible genetic research.

The fundamental ethical principle is that gene expression should be modified only for legitimate and scientifically supported purposes, with adequate protection for individual autonomy, patient safety, genetic privacy and future generations.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT